Emerging analgesic drugs for Parkinson's disease.

@article{PerezLloret2012EmergingAD,
  title={Emerging analgesic drugs for Parkinson's disease.},
  author={Santiago Perez-Lloret and Mar{\'i}a Ver{\'o}nica Rey and Estelle Dellapina and Jean Pellaprat and Christine Brefel-Courbon and Olivier Rascol},
  journal={Expert opinion on emerging drugs},
  year={2012},
  volume={17 2},
  pages={157-71}
}
INTRODUCTION Pain affects between 40 and 85% of Parkinson's disease (PD) patients. It is a frequently disabling and overlooked feature, which can significantly reduce health-related quality of life. Unfortunately, there are no universally recommended treatments for this condition. AREAS COVERED Evidence about the efficacy and safety of available analgesic treatments is summarized in this review. Potential targets for upcoming therapies are then discussed in light of what is currently known… CONTINUE READING
9 Citations
114 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 114 references

Clinical management of pain and fatigue in Parkinson’s disease

  • F Del Sorbo, A. Albanese
  • Parkinsonism Relat Disord 2012;18(Suppl
  • 2012
Highly Influential
4 Excerpts

a balanced and selective norepinephrine- and serotonin-reuptake inhibitor

  • AD Westanmo, J Gayken, R. DuloxetineHaight
  • Am J Health Syst Pharm 2005;62:2481-90 Analgesic…
  • 2012
1 Excerpt

Similar Papers

Loading similar papers…